PannekeetM.M., MulderJ.B., WeeningJ.J., StruijkD.G., ZweersM.M., KredietR.T.Demonstration of aquaporinchip in peritoneal tissue of uremic and CAPD patients.Perit Dial Int1996; 16(Suppl 1): S54–7.
13.
AkibaP., OtaT., FushimiK., TamuraH., HataT., SasakiS.Water channel AQP1, 3, and 4 in the human peritoneum and peritoneal dialysate.Adv Perit Dial1997; 13: 3–5.
14.
CarlssonO., NielsenS., ZakariaE.R., RippeB.In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats.Am J Physiol1996; 271(Heart Circ Physiol 40): H2254–62.
15.
HendersonL.W.Peritoneal ultrafiltration dialysis: Enhanced urea transfer using hypertonic peritoneal dialysis fluid.J Clin Invest1966; 45: 950–5.
16.
NolphK.D., HanoJ.E., TeschanP.E.Peritoneal sodium transport during hypertonic peritoneal dialysis.Ann Intern Med1969; 70: 931–41.
17.
RubinJ., KleinE., BowerJ.D.Investigation of the net sieving coefficient of the peritoneal membrane during peritoneal dialysis.ASAIO J1982; 5: 9–15.
18.
ChenT.W., KhannaR., MooreH., TwardowskiZ.J., NolphK.D.Sieving and reflection coefficients for sodium salts and glucose during peritoneal dialysis.J Am Soc Nephrol1991; 2: 1092–100.
19.
RippeB., PerryM.A., GrangerD.N.Permselectivity of the peritoneal membrane.Microvasc Res1985; 29: 89–102.
ZakariaE.R., RippeB.Osmotic barrier properties of the rat peritoneal membrane.Acta Physiol Scand1993; 149: 355–64.
22.
ImholzA.L.T., KoomenG.C.M., StruijkD.G., AriszL., KredietR.T.Fluid and solute transport in CAPD patients using ultralow sodium dialysate.Kidney Int1994; 46: 333–40.
23.
LeypoldtJ.K.Interpreting peritoneal osmotic reflection coefficients using a distributed model of peritoneal transport.Adv Perit Dial1993; 9: 3–7.
ImholzA.L.T., KoomenG.C.M., StruijkD.G., AriszL., KredietR.T.The effect of dialysate osmolarity on the transport of low molecular weight solutes and proteins during CAPD.Kidney Int1993; 43: 1339–46.
26.
NolphK.D., GhodsA., BrownP., MillerF., HarrisP., PyleK.Effects of nitroprusside on peritoneal mass transfer coefficients and microvascular physiology.ASAIO Trans1977; 23: 210–18.
27.
RenkinE.M.Control of microcirculation and blood-tissue exchange. In: RenkinE.M., MichelC.C., eds. Handbook of physiology. The cardiovascular system. Vol. 4.Washington, D.C.: American Physiological Society1984: 627–87.
28.
MillerF.N., JoshuaI.G., HarrisP.D., WiegmanD.L., JauchemJ.R.Peritoneal dialysis solutions and the microcirculation.Contrib Nephrol1979; 17: 51–8.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
31.
RoseB.D.Clinical physiology of acid-base and electrolyte disorders.2nd ed.New York: McGraw-Hill, 1984: 33.
32.
ImholzA.L.T., KoomenG.C.M., StruijkD.G., AriszL., KredietR.T.The effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD.Kidney Int1993; 44: 1078–85.
33.
TwardowskiZ.J., KhannaR., NolphK.D., ScalamognaA., MetzlerM.H., SchneiderT.W.Intra-abdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis.Nephron1986; 44: 129–35.
KredietR.T., KoomenG.C.M., StruijkD.G., van OldenR.W., ImholzA.L.T., BoeschotenE.W.Practical methods for assessing dialysis efficiency during peritoneal dialysis.Kidney Int1994; 46(Suppl 48): S7–13.
36.
Ho-dac-PannekeetM.M., SchoutenN., LangedijkM.J., HiralallJ.K., de WaartD.R., StruijkD.G.Peritoneal transport characteristics with glucose polymer based dialysate.Kidney Int1996; 50: 979–86.
37.
PannekeetM.M., ImholzA.L.T., StruijkD.G., KoomenG.C.M., LangedijkM.J., SchoutenN.The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients.Kidney Int1995; 48: 866–75.
38.
HeimbürgerO., WaniewskiJ., WerynskiA., LindholmB.A quantitative description of solute and fluid transport during peritoneal dialysis.Kidney Int1992; 41: 1320–32.
39.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., AriszL.The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.Clin Nephrol1987; 27: 51–5.
40.
AlsopR.M.History, chemical and pharmaceutical development of icodextrin.Perit Dial Int1994; 14(Suppl 2): S5–12.
41.
MistryC.D., GokalR.Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis? The role for “colloid” osmosis.Clin Sci1993; 85: 495–500.
42.
RippeB., LevinL.Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.Kidney Int2000; 57: 2546–56.
43.
DoumaC.E., de WaartD.R., StruijkD.G., KredietR.T.Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: A potential role for nitric oxide?Clin Nephrol1996; 45: 295–302.
CanaudB., Liendo–LiendoC., ClaretG., MionH., MionC.Etude “in situ” de la cinétique de l'ultrafiltration en cours de dialyse peritoneale avec périodes de diffusion prolongée.Néphrologie1980; 1: 126–32.
46.
DoumaC.E., HiralallJ.K., De WaartD.R., StruijkD.G., KredietR.T.Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.Kidney Int1998; 53: 1014–21.
47.
HeimbürgerO., WaniewskiJ., WerynskiA., TranæusA., LindholmB.Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.Kidney Int1990; 38: 495–506.
48.
MactierR.A., KhannaR., TwardowskiZ.J., MooreH., NolphK.D.Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.J Clin Invest1987; 80: 1311–16.
49.
KredietR.T., StruijkD.G., KoomenG.C.M., AriszL.Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70.ASAIO Trans1991; 37: 662–7.
50.
RippeB., StelinG., AhlmenJ.Lymph flow from the peritoneal cavity in CAPD patients. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field and Rich, 1986: 24–30.
51.
WangT., ChenC., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis.J Am Soc Nephrol1997; 8: 1915–20.
52.
FlessnerM.F., FenstermacherJ.D., DedrickR.L., BlasborgR.G.Peritoneal absorption of macromolecules studied by quantitative autoradiography.Am J Physiol1985; 248: H26–32.
ZakariaE.R., RippeB.Peritoneal fluid and tracer albumin kinetics in the rat. Effects of increases in intraperitoneal hydrostatic pressure.Perit Dial Int1995; 15: 118–28.
55.
KredietR.T., BoeschotenE.W., StruijkD.G., AriszL.Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges.Nephrol Dial Transplant1988; 2: 198–204.
56.
ImholzA.L.T., KoomenG.C.M., VoornW.J., StruijkD.G., AriszL., KredietR.T.Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD.Nephrol Dial Transplant1998; 13: 146–53.
57.
MactierR.A., KhannaR., TwardowskiZ.J., MooreH., NolphK.D.Influence of phosphatidylcholine on lymphatic absorption during peritoneal dialysis in the rat.Perit Dial Int1988; 8: 179–86.
58.
StruijkD.G., van der ReijdenH.J., KredietR.T., KoomenG.C.M., AriszL.Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis.Nephron1989; 51: 577–8.
59.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., van der ReijdenH.J., AriszL.Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients.Perit Dial Int1990; 10: 141–5.
60.
KredietR.T., StruijkD.G., BoeschotenE.W., HoekF.J., AriszL.Measurement of intraperitoneal fluid kinetics in CAPD patients by means of autologous hemoglobin.Neth J Med1988; 33: 281–90.
61.
KredietR.T., StruijkD.G., KoomenG.C.M., HoekF.J., AriszL.The disappearance of macromolecules from the peritoneal cavity during continuous ambulatory peritoneal dialysis (CAPD) is not dependent on molecular size.Perit Dial Int1990; 10: 147–52.
62.
KruseM., MahioutA., KliemV., KurzP., KochK.M., BrunkhorstR.Interleukin-1β stimulates glucose uptake of human peritoneal mesothelial cells.Perit Dial Int1996; 16(Suppl 1): S58–60.
63.
SchröppelB., FischerederM., WieseP., SegererS., HuberS., KretzlerM.Expression of glucose transporters in human peritoneal mesothelial cells.Kidney Int1998; 53: 1278–87.
64.
WaniewskiJ., HeimbürgerO., WerynskiA., LindholmB.Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis.Nephrol Dial Transplant1992; 7: 50–6.
65.
NolphK.D., TwardowskiZ.J., PopovichR.P., RubinJ.Equilibration of peritoneal dialysis solutions during long-dwell exchanges.J Lab Clin Med1979; 93: 246–56.
66.
WangT., WaniewskiJ., HeimbürgerO., WerynskiA., LindholmB.A quantitative analysis of sodium transport and removal during peritoneal dialysis.Kidney Int1997; 52: 1609–16.
67.
RajaR.M., CantorR.E., BoreykoC., BushehriH., KramerM.S., RosenbaumJ.L.Sodium transport during ultra-filtration peritoneal dialysis.ASAIO Trans1972; 18: 429–33.
68.
LeypoldtJ.K., CharneyD.I., CheungA.K., NaprestekC.L., AkinB.H., ShockleyT.R.Ultrafiltration and solute kinetics using low sodium peritoneal dialysate.Kidney Int1995; 48: 1959–66.
69.
MarfisL., SerkesK.D., NolphK.D.Calcium carbonate as a phosphate binder: Is there a need to adjust peritoneal calcium concentrations in patients using CaCO3?Perit Dial Int1989; 9: 325–8.
70.
RippeB., LevinL.Should dialysate calcium be varied in proportion to the amount of ultrafiltration in peritoneal dialysis dwells? Directions from a computer simulation.Perit Dial Int1998; 18: 474–7.
71.
BlakeP.G., SomolasK., IzattS., OreopoulosD.G.A highly permeable peritoneal membrane is an adverse risk factor in CAPD.Clin Invest Med1991; 14: 127.
72.
HeafJ.CAPD adequacy and dialysis morbidity: Detrimental effect of a high peritoneal equilibration rate.Ren Fail1995; 17: 575–87.
73.
DaviesS.J., BryanJ., PhillipsL., RussellG.I.The predictive value of KT/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present.Perit Dial Int1996; 16(Suppl 1): S158–62.
74.
WuC., HuangC., HuangJ., WuM., LeuM.High flux peritoneal membrane is a risk factor in survival of CAPD treatment.Adv Perit Dial1996; 12: 105–9.
75.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PagéD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients.J Am Soc Nephrol1998; 9: 1285–92.
76.
WangT., WaniewskiJ., HeimbürgerO., BergströmJ., WerynskiA., LindholmB.A simple and fast method to estimate peritoneal membrane transport characteristics using dialysate sodium concentration.Perit Dial Int (in press).
KeshaviahP., EmersonP.F., VoneshE.F., BrandesJ.C.Relationship between body size, fill volume and mass transfer area coefficient in peritoneal dialysis.J Am Soc Nephrol1994; 4: 1820–6.
79.
WangT., HeimbürgerO., ChengH., WaniewskiJ., BergströmJ., LindholmB.Effects of dialysate fill volume on peritoneal fluid and solute transport.Kidney Int1997; 52: 1068–76.
80.
WangT., ChengH., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Hyaluronan prevents the decrease in net fluid removal caused by increased dialysate fill volume.Kidney Int1998; 53: 496–502.
81.
ZhuQ., CarlssonO., RippeB.Clearance of tracer albumin from peritoneal cavity to plasma at low intraperitoneal volumes and hydrostatic pressures.Perit Dial Int1998; 18: 497–504.
82.
DrakeR.E., GabelJ.C.Diaphragmatic lymph vessel drainage of the peritoneal cavity.Blood Purif1992; 10: 132–5.
83.
RajaR.M., KramerM.S., RosenbaumJ.L., BolisayC., KrugM.Contrasting changes in solute transport and ultra-filtration with peritonitis in CAPD patients.ASAIO Trans1981; 27: 68–70.
84.
RubinJ., RayR., BarnesT., BowerJ.Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.Nephron1981; 29: 124–7.
85.
RubinJ., McFarlandS., HellemsE.W., BowerJ.D.Peritoneal dialysis during peritonitis.Kidney Int1981; 19: 460–4.
86.
RajaR.M., KramerM.S., BarberK.Solute transport and ultrafiltration during peritonitis in CAPD patients.ASAIO J1984; 7: 8–11.
87.
KredietR.T., ZuyderhoudtM.J., BoeschotenE.W., AriszL.Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients.Eur J Clin Invest1987; 17: 43–52.
88.
VergerC., LugerA., MooreH.L., NolphK.D.Acute changes in peritoneal transport properties with infectious peritonitis and mechanical injury.Kidney Int1983; 23: 823–31.
89.
DoumaC.E., de WaartD.R., StruijkD.G., KredietR.T.Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?J Lab Clin Med1998; 132: 329–40.
90.
WiderøeT.E., SmebyL.C., MjålandS., DahlK., BergL.J., AasT.W.Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.Nephron1984; 38: 238–47.
91.
ZemelD., BetjesM.G.H., DinklaC., StruijkD.G., KredietR.T.Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.Perit Dial Int1995; 15: 134–41.
92.
KredietR.T., AriszL.Fluid and solute transport across the peritoneum during continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1989; 9: 15–25.
93.
HaraldssonB.Assessing the peritoneal dialysis capacities of individual patients.Kidney Int1995; 47: 1187–98.
SteinhauerH.B., SchollmeyerP.Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.Kidney Int1986; 29: 584–90.
96.
ZemelD., KoomenG.C.M., HartA.A.M., ten BergeR.J.M., StruijkD.G., KredietR.T.Relationship of TNF-α, interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.J Lab Clin Med1993; 122: 686–96.
97.
ZemelD., StruijkD.G., DinklaC., StolkL.M., ten BergeR.J.M., KredietR.T.Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.J Lab Clin Med1995; 126: 204–15.
98.
DoumaC.E., de WaartD.R., StruijkD.G., KredietR.T.The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.Kidney Int1997; 51: 1885–92.
99.
GokalR., JakubowskiC., KingJ., HuntL., BogleS., BaillardR.Outcome in patients on continuous ambulatory peritoneal dialysis: 4 year analysis of a prospective multicentre study.Lancet1987; 2: 1105–8.
100.
CANUSA Peritoneal Dialysis Study Group.Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: Association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
101.
GenestierJ., HedelinG., SchafferP., FallerB.Prognostic factors in CAPD patients: A retrospective study of a 10-year period.Nephrol Dial Transplant1995; 10: 1905–11.
102.
KredietR.T., DoumaC.E., van OldenR.W., Ho-dac-PannekeetM.M., StruijkD.G.Augmenting solute clearance in peritoneal dialysis.Kidney Int1998; 54: 2218–35.
103.
KawaguchiY., HasegawaT., NakayamaM., KuboH., ShigematuT.Issues affecting the longevity of the continuous peritoneal dialysis therapy.Kidney Int1997; 52(Suppl 62): S105–7.
104.
Ho-dac-PannekeetM.M., AtaseverB., StruijkD.G., KredietR.T.Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis.Perit Dial Int1997; 17: 144–50.
105.
RippeB.How to measure ultrafiltration failure: 2.27% or 3.86% glucose?Perit Dial Int1997; 17: 125–8.
106.
VirgaG., AmiciG., DaRinG., VianelloA., CalconiG., Da PortoA.Comparison of fast peritoneal equilibration test with 1.36 and 3.86% dialysis solutions.Blood Purif1994; 12: 113–20.
107.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., AriszL.Peritoneal transport characteristics of water, low molecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis.Perit Dial Bull1986; 6: 61–5.
108.
DaviesS.J., BrownB., BryanJ., RussellG.I.Clinical evaluation of the peritoneal equilibration test: A population-based study.Nephrol Dial Transplant1993; 8: 64–70.
109.
HeimbürgerO., WaniewskiJ., WerynskiA., ParkM.S., LindholmB.Dialysate to plasma concentration (D/P) versus peritoneal transport parameters in CAPD.Nephrol Dial Transplant1994; 9: 47–59.
110.
MonquilM.C.J., ImholzA.L.T., StruijkD.G., KredietR.T.Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?Perit Dial Int1995; 15: 42–8.
111.
ZweersM.M., StruijkD.G., KredietR.T.Correcting sodium sieving for diffusion from circulation.Adv Perit Dial1999; 15: 65–72.
112.
SmitW., LangedijkM.J., SchoutenN., van den BergN., StruijkD.G., KredietR.T.A comparison between 1.36% and 3.86% glucose dialysis solutions for the assessment of peritoneal membrane function.Perit Dial Int (in press).
113.
VergerC., LarpentL., CelicoutB.Clinical significance of ultrafiltration failure on CAPD. In: La GrecaG., ChiaramonteS., FabrisA., FerianiM., RoncoC., eds. Peritoneal dialysis.Milan: Wichtig Editore, 1986: 91–4.
114.
KredietR.T., StruijkD.G., BoeschotenE.W., KoomenG.C.M., StouthardJ.M.L., HoekF.J.The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.Am J Kidney Dis1989; 13: 299–307.
115.
WaniewskiJ., HeimbürgerO., WerynskiA., LindholmB.Osmotic conductance of the peritoneum in CAPD patients with permanent loss of ultrafiltration capacity.Perit Dial Int1996; 16: 488–96.
116.
SlingeneyerA., CanaudB., MionC.Permanent loss of ultrafiltration capacity of peritoneum in long-term peritoneal dialysis.Nephron1983; 33: 133–8.
117.
Ho-dac-PannekeetM.M., KoopmansJ.G., StruijkD.G., KredietR.T.Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis.Adv Perit Dial1997; 13: 17–22.
118.
StruijkD.G., KredietR.T., KoomenG.C.M., HoekF.J., BoeschotenE.W., van der ReijdenH.J.Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis.Nephron1991; 59: 213–20.
119.
GoffinE., CombetS., JamarF., CosynsJ-P, DevuystO.Expression of aquaporin-1 (AQP1) in a long-term peritoneal dialysis patient with impaired transcellular water transport.Am J Kidney Dis1999; 33: 383–8.
120.
KredietR.T.Loss of membrane permeability: A threat for CAPD. In: AndreucciV.E., FineL.G., eds. International yearbook of nephrology 1997.New York: Oxford University Press, 1997: 153–62.
121.
HeimbürgerO., WaniewskiJ., WerynskiA., ParkM.S., LindholmB.Lymphatic absorption in CAPD patients with permanent loss of ultrafiltration capacity.Blood Purif1995; 13: 327–39.
122.
VergerC., CelicoutB.Peritoneal permeability and encapsulating peritonitis.Lancet1985; 1: 986–7.
123.
GotloibL., ShostakA., Bar-ShellaP., CohenR.Continuous mesothelial injury and regeneration during long-term peritoneal dialysis.Perit Dial Int1987; 7: 148–55.
124.
PannekeetM.M., ZemelD., KoomenG.C.M., StruijkD.G., KredietR.T.Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.Perit Dial Int1995; 15: 217–25.
125.
Hagmolen of ten Have W, Ho-dac-PannekeetM.M., StruijkD.G., KredietR.T.Mesothelial regeneration after peritonitis in dialysis patients.J Am Soc Nephrol1997; 8: 180A.
126.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., HoekF.J., AriszL.A prospective study of peritoneal transport in CAPD patients.Kidney Int1994; 45: 1739–44.
127.
AndreoliS.P., LangefeldC.D., StadlerS., SmithP., SearsA., WestK.Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis.Pediatr Nephrol1993; 7: 543–7.
128.
OulèsR., ChallahS., BrunnerF.P.Case-control study to determine the cause of sclerosing peritoneal disease.Nephrol Dial Transplant1988; 3: 66–9.
129.
HendriksPMEM, Ho-dac-PannekeetM.M., van GulikT.M., StruijkD.G., PhoaSSKS, SieL.Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics.Perit Dial Int1997; 17: 136–43.
130.
SelgasR., Fernandez–ReyesM.J., BosqueE., BajoM-A, BorregoF., JimenezC.Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.Am J Kidney Dis1994; 23: 64–73.
131.
DaviesS.J., BryanJ., PhillipsL., RussellG.I.Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis.Nephrol Dial Transplant1996; 11: 498–506.
132.
KredietR.T.Preserving the integrity of the peritoneal membrane in chronic peritoneal dialysis.Kidney Int1999; 55: 341–56.
133.
GotloibL., ShostakA., WaysbrotV.Detrimental effects of peritoneal dialysis solutions upon in vivo and in situ exposed mesothelium.Perit Dial Int1997; 17(Suppl 2): S13–16.
134.
Di PaoloN., SacchiG.Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): An in vivo model for the study of diabetic micro-angiopathy.Perit Dial Int1989; 9: 41–5.
135.
MateijsenM.A.M., van der WalA.C., HendriksPMEM, ZweersM.M., MulderJ., KredietR.T.Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.Perit Dial Int1999; 19: 517–25.
136.
HondaK., NittaK., HoritaS., YumuraW., NikeiW.Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure.Nephron1996; 72: 171–6.
137.
ZweersM.M., MulderJ.B., KredietR.T., StruijkD.G.Vascular and interstitial changes in a continuous peritoneal infusion model in the rat.J Am Soc Nephrol1998; 9: 195A.
138.
YamadaK., MiyakasaY., HamaguchiK., NakayamaM., NakanoH., NozakiO.Immunohistochemical study of human advanced glycosylation end products (AGE) in chronic renal failure.Clin Nephrol1994; 42: 354–61.
139.
NakayamaM., KawaguchiY., YamadaK., HasegawaT., TakazoeK., KatokN.Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD.Kidney Int1997; 51: 182–6.
140.
FerraraN.Vascular endothelial growth factor. The trigger for neovascularization in the eye.Lab Invest1995; 72: 615–18.
141.
SharmaK., ZiyadehF.N.Hyperglycemia and diabetic kidney disease. The call for transforming growth factor-β as a key mediator.Diabetes1995; 44: 1139–46.
142.
ZweersM.M., de WaartD.R., StruijkD.G., KredietR.T.The growth factors VEGF and TGF-β1 in peritoneal dialysis.J Lab Clin Med1999; 134: 124–32.
143.
AielloL.P., AveryR.L., ArriggP.G., KeytB.A., JampelH.D., ShakS.T.Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.N Engl J Med1994; 331: 1480–7.
StruijkD.G., KredietR.T., ImholzA.L.T., KoomenG.C.M., AriszL.Fluid kinetics in CAPD patients during dialysis with a bicarbonate-based hypoosmolar solution.Blood Purif1996; 14: 217–26.
146.
DaugirdasJ.T., IngT.S., GandhiV.C., HanoJ.E., ChenW.T., YuanT.Kinetics of peritoneal fluid absorption in patients with chronic renal failure.J Lab Clin Med1980; 95: 351–61.
147.
HendersonL.W., NolphK.D.Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.J Clin Invest1969; 48: 992–1001.
148.
KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., StrackeeJ., AriszL.Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients.Blood Purif1986; 4: 194–203.
149.
WaniewskiJ., WerynskiA., HeimbürgerO., LindholmB.Simple models for description of small-solute transport in peritoneal dialysis.Blood Purif1991; 9: 129–41.
150.
WaniewskiJ., WerynskiA., HeimbürgerO., LindholmB.A comparative analysis of mass transport models in peritoneal dialysis.ASAIO Trans1991; 37: 65–75.
151.
WaniewskiJ., HeimbürgerO., WerynskiA., ParkM.S., LindholmB.Diffusive and convective solute transport in peritoneal dialysis with glucose as an osmotic agent.Artif Organs1995; 19: 295–306.
152.
LindholmB., WerynskiA., BergströmJ.Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents.ASAIO J1983; 6: 131–7.
153.
VoneshE.F., RippeB.Net fluid absorption under membrane transport models of peritoneal dialysis.Blood Purif1992; 10: 209–26.